tiprankstipranks
Calidi Biotherapeutics (CLDI)
XASE:CLDI
US Market
CLDI
Calidi Biotherapeutics
RESEARCH TOOLSreports

Calidi Biotherapeutics (CLDI) Income Statement

361 Followers

Calidi Biotherapeutics Income Statement

Last quarter (Q4 2025), Calidi Biotherapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Calidi Biotherapeutics's net income was $-4.06M. See Calidi Biotherapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Mar 25Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 45.00K$ 449.00K
Gross Profit
$ -1.65M$ 0.00$ -1.26M$ -229.00K$ 355.00K
Operating Expenses
$ 18.59M$ 21.78M$ 27.74M$ 22.90M$ 10.84M
Depreciation and Amortization
$ 1.65M$ 1.53M$ 1.26M$ 260.00K$ 156.00K
EBITDA
$ -18.59M$ -19.73M$ -24.20M$ -25.00M$ -9.45M
Operating Income
$ -20.24M$ -21.78M$ -28.99M$ -23.13M$ -10.48M
Other Income/Expenses
$ 192.00K$ -419.00K$ -208.00K$ -2.29M$ 13.88M
Pretax Income
$ -20.05M$ -22.20M$ -29.20M$ -25.42M$ 3.40M
Net Income
$ -19.91M$ -22.14M$ -29.22M$ -25.43M$ -10.93M
Per Share Metrics
Basic EPS
$ -5.95$ -35.70$ -207.61$ -358.80$ 14.16
Diluted EPS
$ -5.95$ -35.70$ -207.61$ -358.80$ 14.16
Weighted Average Shares Outstanding
 4.30M 664.41K 140.16K 70.59K 238.63K
Weighted Average Shares Outstanding (Diluted)
 4.30M 664.41K 140.16K 70.59K 238.63K
Currency in USD

Calidi Biotherapeutics Earnings and Revenue History